4.4 Article

Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors

Journal

CHEMICAL BIOLOGY & DRUG DESIGN
Volume 94, Issue 6, Pages 2023-2030

Publisher

WILEY
DOI: 10.1111/cbdd.13604

Keywords

flavonoid; FRET; inhibitory compounds; MERS-CoV; MERS-CoV 3CLpro

Funding

  1. National Research Foundation of Korea [2018R1D1A1B07050781, 2016R1A6A3A11935354, 2018R1D1A1B07050942]
  2. Ministry of Education, Science and Technology, Republic of Korea (MEST)
  3. Brain Korea 21
  4. National Research Foundation of Korea [2018R1D1A1B07050942, 2018R1D1A1B07050781, 2016R1A6A3A11935354] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Middle East respiratory syndrome-coronavirus (MERS-CoV) is a zoonotic virus transmitted between animals and human beings. It causes MERS with high mortality rate. However, no vaccine or specific treatment is currently available. Since antiviral activity of some flavonoids is known, we applied a flavonoid library to probe inhibitory compounds against MERS-CoV 3C-like protease (3CLpro). Herbacetin, isobavachalcone, quercetin 3-beta-d-glucoside and helichrysetin were found to block the enzymatic activity of MERS-CoV 3CLpro. The binding of the four flavonoids was also confirmed independently using a tryptophan-based fluorescence method. The systematic comparison of the binding affinity of flavonoids made it possible to infer their scaffolds and functional groups required to bind with MERS-CoV 3CLpro. An induced-fit docking analysis revealed that S1 and S2 sites play a role in interaction with flavonoids. The experimental and computational study showed that flavonol and chalcone are favourite scaffolds to bind with the catalytic site of MERS-CoV 3CLpro. It was also deduced that some flavonoid derivatives with hydrophobic or carbohydrate attached to their core structures have a good inhibitory effect. Therefore, we suggest that flavonoids with these characteristics can be used as templates to develop potent MERS-CoV 3CLpro inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available